Adversity, Brain, and Opioid Use Study

This study is looking at how the brain processes and remembers information, especially in relation to past difficult experiences and Opioid Use Disorder (OUD). Researchers want to understand brain function and performance during learning and memory tasks. You might be eligible if you are between 18 and 55 years old, speak English fluently, and have normal vision and hearing. The study is comparing three groups: people with OUD who are taking buprenorphine, people without OUD who are taking buprenorphine, and healthy adults who are not taking buprenorphine. The main goals are to see differences in brain activity (Blood Oxygen Level Dependent or BOLD signal), brain volume, and brain connections in a specific area called the hippocampus. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 185 participants across three groups. It is not specified if the study is randomized or blinded.
What's involved
You would have two visits. On Day 1, you would complete computer tasks. On Day 2, you would have an MRI scan while completing various tasks.
Compensation
Not stated in the trial record.
Follow-up
The primary measurements are taken on Day 2 (MRI task visit).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06355778

Adversity, Brain and Opioid Use Study

Recruiting
NAAges 18–55InterventionalBasic science
University of Michigan
~185 participants
Updated 2026-07-17 on ClinicalTrials.gov
What's tested:Magnetic Resonance Imaging (MRI)Computer Tasks

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Differences in Blood Oxygen Level Dependent (BOLD) signal in the hippocampus
Measured over Day 2 (MRI task visit)
+6 more outcomes measured
Opioid Use Disorder
Healthy
1 sites across 1 states
Michigan1
  • Elizabeth Duval · PRINCIPAL_INVESTIGATOR · University of Michigan

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Fluent in English
Able to give informed consent
Normal/corrected-to-normal vision and hearing
Diagnosis of OUD
Be actively receiving buprenorphine (BUP) for opioid agonist therapy
Be free from illicit substance use for at least 2 weeks
The study will allow stable dose (\> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)
Taking BUP for chronic pain
No Substance Use Disorder (including OUD)
The study will allow stable dose (\> 3 months) of commonly prescribed psychiatric medications and some sleep aids (per protocol)
Not taking BUP
Free of any psychiatric or major medical conditions

Exclusion

Pregnancy
Significant medical or neurologic conditions (e.g., stroke, seizures, multiple sclerosis)
Actively suicidal
Contraindication for MRI
Inability to tolerate small, enclosed spaces without anxiety or unable to fit comfortably in the MRI scanner
Life history of schizophrenia, learning disability, attention deficit disorder, or pervasive developmental disorder
Use of substances or prescription medications that could interfere with measures of interest (per protocol)
Unable to provide informed consent
Participants who have completed other studies in our lab involving learning and memory assessments with the same/similar tasks used here (HUM00230585, HUM00121812) will not be eligible to complete the current study, due to possible learning/practice effects
  • Differences in Blood Oxygen Level Dependent (BOLD) signal in the hippocampusDay 2 (MRI task visit)

    BOLD signal during functional magnetic resonance imaging (fMRI) will be used as a measure of hippocampus activation when remembering common objects and scenes. The study team will examine differences between participants with Opioid Use Disorder (OUD) and those without OUD.

  • Differences in Hippocampal (Hpc) volumeDay 2 (MRI task visit)

    T-1 weighted structural images for each participant will be used to compute the volume of the hippocampus in people with OUD compared to those without OUD.

  • Differences in hippocampal circuit connectivityDay 2 (MRI task visit)

    Functional connectivity, measured with BOLD signal will be used to examine functional connectivity between the hippocampus, amygdala, and prefrontal cortex. The study team will examine differences in connectivity between participants with OUD and those without OUD.

  • Differences in performanceDay 1 (computer tasks visit)

    Number of correct responses will be used to assess memory for common objects and scenes. Differences in memory will be examined in between participants with OUD and those without OUD.

  • Differences in performanceDay 2 (MRI task visit)

    Number of correct responses will be used to assess memory for common objects and scenes. Differences in memory will be examined in between participants with OUD and those without OUD.

  • Differences in threat reactivity measured via skin conductance response (SCR)Day 1 (computer tasks visit)

    Electrodermal activity collected with a bioamplifier will be used to quantify physiological reactivity to threat. Event related SCR will be measured as a baseline corrected response (peak minus baseline) to cues that predict threat compared to cues that do not predict threat. Differences in SCR between participants with OUD and participants without OUD will be examined.

  • Differences in threat reactivity measured via skin conductance response (SCR)Day 2 (MRI task visit)

    Electrodermal activity collected with a bioamplifier will be used to quantify physiological reactivity to threat. Event related SCR will be measured as a baseline corrected response (peak minus baseline) to cues that predicted threat on the previous day compared to cues that did not predict threat. Differences in SCR between participants with OUD and participants without OUD will be examined.